Harrison Bay Life Sciences (HBLS), a medical device commercialisation partner, is bringing its medical products and services to the United States (US) market.
HBLS is headquartered in Chattanooga, Tennessee, and recently announced the growth of its business within the US. HBLS aids medical device companies that are seeking a commercialisation partner to help bring medical products and services to market.
As launching a product in the United States can be particularly challenging, HBLS aims to simplify this process for companies through its unique infrastructure and experienced team, who will provide medical device start-up companies with the knowledge to successfully achieve and maintain profitability throughout a product’s lifecycle. HBLS will guide products through market analysis and market development, clinical trials and FDA approval, market entry and promotion, logistics, delivery, and inventory management, and provide clinical support.
HBLS will also allow companies to make the most of its existing relationships and credentials with hospitals, outpatient surgery centres, group purchasing organisations, and physician practices. Additionally, HBLS will provide access to its proprietary logistics and fulfilment systems, military-grade cybersecurity protocols, and consulting.
HBLS is able to support its clients via a remote case/procedure support imaging tool. This allows users to have a 360 degree view of a surgical suite via the technology, and ensures that technicians can support physicians remotely – removing the need for travel. This feature is particularly beneficial at the moment as we are coping with the global Covid-19 pandemic.